ECR 2025, Europe's largest radiology conference, was held in Vienna, Austria, from March 2 to March 26, 2025. As it has become an important event for sharing the latest technologies and research results from around the world and discussing the direction of development in the field of radiology, CorelineSoft has been attending every year. According to the ECR 2025 organizers, this year's event boasted 20,522 visitors from 131 countries, an increase of 9% over last year's event, with interest in the event growing rapidly due to the implementation of national lung cancer screening in Germany and the mandatory use of AI image analysis.
CorelineSoft has also made significant achievements over the past year, further developing its AI-based image diagnosis software AVIEW through more in-depth research and clinical cases. Let's take a look at some of the highlights of ECR 2025 from CorelineSoft's perspective.
Every year, the European Congress of Radiology chooses a theme that reflects the key issues and future of the medical community to foster knowledge exchange between professionals and companies. This year, the theme for ECR 2025 was “Planet Radiology,” emphasizing the sustainability, social responsibility, and scientific approach of radiology. Specifically, it aimed to explore the connection between radiology and global environmental issues, emphasize the role of radiology in promoting global health equity, and practice responsible radiology for future generations.
At CorelineSoft, we have “altruism” as our core value, and we deeply resonate with these themes and directions. We strive not only to provide solutions, but also to contribute to building a sustainable medical ecosystem.
ECR 2025 (https://connect.myesr.org/ecr-2025/ecr-2025-photo-gallery/)
At ECR 2025, CorelineSoft unveiled its completely revamped All New AVIEW lineup, including its flagship product, AVIEW LCS Plus. Having already demonstrated its competitiveness in the global lung cancer screening market through the 5-country multinational lung cancer screening project in Europe (4lTLR), the German lung cancer screening project (HANSE), and the lung cancer screening project involving 18 hospitals and cancer oncology centers in Italy (RISP), CorelineSoft showcased its advanced technology at the exhibition.
Recently, CorelineSoft has received various certifications at home and abroad in recognition of the excellence of its AI-based medical solutions. In October 2024, CorelineSoft received the European CE MDR certification and UK Conformity Assessed (UKCA), and in January 2025, CorelineSoft simultaneously received the European GDPR and US HIPAA compliance certifications. In February 2025, an advanced version of AVIEW CAC, an AI-based coronary artery calcification analysis software, received 510(k) certification from the U.S. Food and Drug Administration (FDA), demonstrating the results of our continuous research and development.
These achievements were also felt intimately on the ground. Visitors to the CorelineSoft booth, including doctors, industry leaders, and other professionals, engaged in in-depth discussions about the latest technologies and innovative solutions. The opportunities provided by ECR 2025 reaffirmed the importance of advancement and collaboration in healthcare.
CorelineSoft's significant achievements over the past year were on full display at the booth, where the completely revamped All New AVIEW was available for hands-on demonstration, and first-time visitors, as well as medical staff who have already reviewed the software in medical research and clinical settings, showed great interest in the enhanced, user-friendly software. In particular, inquiries about AVIEW LCS Plus, which can simultaneously screen for lung cancer, emphysema, and coronary artery calcification, were received with great enthusiasm, demonstrating the growth potential of not only CorelineSoft but also the AI-based medical industry.
Having attended ECR every year for the past few years, CorelineSoft has realized that the enthusiasm of our customers has grown year after year. This year's ECR 2025 saw a higher level of participation than ever before, cementing our position as a leader in AI-powered imaging diagnostic solutions. This is thanks to our partners and customers for their deep trust in our technology and continued support. We sincerely thank you for your unwavering support and cooperation, and look forward to creating better healthcare solutions together!
If you have any insights from ECR 2025 or additional questions, please feel free to contact us.
Contact us
General inquiries
Business Department
Overseas Business Department
Customer Service Team
IR-related inquiries
List